(Q33378959)

English

Phase II study of fotemustine in recurrent supratentorial malignant gliomas

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

26 July 2017

Phase II study of fotemustine in recurrent supratentorial malignant gliomas (English)

1 reference

stated in

Europe PubMed Central

26 July 2017

Frenay M

1

1 reference

stated in

Europe PubMed Central

PubMed ID

1834116

retrieved

26 July 2017

Giroux B

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

1834116

retrieved

26 July 2017

Khoury S

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

1834116

retrieved

26 July 2017

Derlon JM

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed ID

1834116

retrieved

26 July 2017

Namer M

series ordinal

5

1 reference

stated in

Europe PubMed Central

26 July 2017

1 January 1991

1 reference

stated in

Europe PubMed Central

26 July 2017

European Journal of Cancer

1 reference

stated in

Europe PubMed Central

26 July 2017

27

1 reference

stated in

Europe PubMed Central

26 July 2017

7

1 reference

stated in

Europe PubMed Central

26 July 2017

852-856

1 reference

stated in

Europe PubMed Central

PubMed ID

1834116

retrieved

26 July 2017

Identifiers

DOI

10.1016/0277-5379(91)90133-X

1 reference

stated in

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

PubMed ID

1834116

retrieved

26 July 2017

(Q33378959)

Phase II study of fotemustine in recurrent supratentorial malignant gliomas

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)